TXNDC9 and hepatocellular carcinoma: In agreement with the results from immunohistochemical staining, TXNDC9 mRNA levels in HCC tissues were significantly upregulated in 23 of 50 cases (46.0%, fold change ≥ 2, Fig. 1b).